Nap B.V. Forgrowth Sells 25,132 Shares of NewAmsterdam Pharma (NASDAQ:NAMS) Stock
NewAmsterdam Pharma (NASDAQ:NAMS – Get Free Report) major shareholder Nap B.V. Forgrowth sold 25,132 shares of the firm’s ...
HealthPrep on MSN5 天
11 Gallbladder-Gratifying Diet Hacks to Keep Your Body in Blissful Balance
Even though the gallbladder is often forgotten, it is vital to everyone's overall health to keep it functioning well.
ETF Daily News6 天
Q1 Earnings Forecast for NAMS Issued By Leerink Partnrs
NewAmsterdam Pharma (NASDAQ:NAMS – Free Report) – Equities researchers at Leerink Partnrs issued their Q1 2025 earnings ...
Medscape5 天
Twenty-five Years of Statins: Where Do We Go From Here?
Cardiovascular outcomes trials with experimental cholesteryl ester transfer protein inhibitors will provide crucial data on the viability of pharmacological strategies to raise HDL-cholesterol.
Yahoo Finance4 天
NewAmsterdam Pharma Company N.V. (NAMS)
After hours: December 24 at 3:41:03 p.m. EST ...
Medscape4 天
Nanotechnology in Therapeutics
Nanomedicine. 2012;7(8):1253-1271. Liposomes Liposomes are self-assembled artificial vesicles developed from amphiphilic phospholipids. These vesicles consist of a spherical bilayer structure ...